When Should We Adopt EUS-Guided Radiofrequency Ablation in Pancreatic Neuroendocrine Tumors?

Moreover, in the specific setting of insulinoma, it is strongly recommended that patients are administered a continuous 10% dextrose infusion prior to the procedure and that close glucose-level monitoring is employed, during and at least 24 hours beforehand; this is in order to prevent severe hypoglycemia, which may occur as a consequence of tumor cell necrosis [[15]]. Pancreatic neuroendocrine neoplasms can be divided into functional (F-PanNENs) and non-functional (NF-PanNENs) neoplasms. Pancreatic neuroendocrine neoplasms (PanNENs) are rare and heterogeneous diseases that account for less than 2% of all cases of pancreatic cancer and only 30% of digestive neuroendocrine neoplasia, even if their incidence and prevalence continue to rise globally [[1]]. [Extracted from the article]